Debio1143 - Head & Neck Cancer
Head and Neck Cancer – Debio1143 prolonged patient lives
Background 3-year follow-up results from the randomized phase II study assessing the efficacy and safety of Debio 1143 in combination with chemo-radiation therapy vs. chemo-radiation therapy alone. The treatment was…